Mutation spectrum of COL1A1/COL1A2 screening by high-resolution melting analysis of Chinese patients with osteogenesis imperfecta

被引:0
作者
Mingyan Ju
Xue Bai
Tianke Zhang
Yunshou Lin
Li Yang
Huaiyu Zhou
Xiaoli Chang
Shizhen Guan
Xiuzhi Ren
Keqiu Li
Yi Wang
Guang Li
机构
[1] Tianjin Medical University,Department of Genetics
[2] Tianjin Hospital,Department of Medical Laboratory
[3] Tianjin People’s Hospital,Colorectal Surgery
[4] Tianjin Medical University,School of Basic Medical Sciences
[5] Wuqing People’s Hospital,Orthopedic Ward III
来源
Journal of Bone and Mineral Metabolism | 2020年 / 38卷
关键词
Osteogenesis imperfecta; Phenotypes; HRM; Chinese;
D O I
暂无
中图分类号
学科分类号
摘要
High-resolution melting (HRM) analysis has been shown to be a time-saving method for the screening of genetic variants. To increase the precision of the diagnosis of osteogenesis imperfecta (OI), we used HRM to explore COL1A1/COL1A2 mutations in 87 Chinese OI patients and to perform population-based studies of the relationships between their genotypes and phenotypes. Peripheral blood samples were collected from the 87 non-consanguineous probands. The coding regions and exon boundaries of COL1A1/COL1A2 were detected by HRM and confirmed by Sanger sequencing. The functional effects of mutations were predicted through bioinformatic tools. Mutations were detected in 70.3% of familial cases and 40% of sporadic cases (p < 0.01). Compared with COL1A1 mutations, patients with COL1A2 mutations were more prone to severe phenotypes. Helical mutations (caused by substitution of the glycine within the Gly–X–Y triplet domain) were more likely to occur in patients with type III and IV (p < 0.05). Haploinsufficiency mutations (caused by frameshift, nonsense, and splice-site mutations) appeared more frequently in patients with type I (p < 0.05). Compared with the Sanger sequencing and whole exome sequencing (WES), HRM was found to reduce total costs by 78%– 80% in patients who had a positive HRM separate melting curve. Our findings suggest that HRM would greatly benefit small and understaffed hospitals and laboratories, and would facilitate the accurate diagnosis and early treatment of OI in remote and less developed regions.
引用
收藏
页码:188 / 197
页数:9
相关论文
共 187 条
  • [1] Glorieux FH(2008)Osteogenesis imperfecta Best Pract Res Clin Rheumatol 22 85-100
  • [2] Van Dijk FS(2014)Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment Am J Med Genet A 164A 1470-1481
  • [3] Sillence DO(2009)Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships Hum Mol Genet 18 463-471
  • [4] Bodian DL(1979)Chain conformation in the collagen molecule J Mol Biol 129 463-481
  • [5] Chan TF(2002)Folding and conformational consequences of glycine to alanine replacements at different positions in a collagen model peptide Biochemistry 41 6539-6547
  • [6] Poon A(2012)EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta Eur J Hum Genet 20 11-19
  • [7] Schwarze U(2014)Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment Am J Med Genet A 164A 1470-1481
  • [8] Yang K(2008)Synthetic collagen heterotrimers: structural mimics of wild-type and mutant collagen type I J Am Chem Soc 130 7509-7515
  • [9] Byers PH(2014)Technology: the $1,000 genome Nature 507 294-295
  • [10] Kwok PY(2013)Next-generation sequencing: methodology and application J Invest Dermatol 133 e11-380